The U.S. Food and Drug Administration (FDA) has issued new draft guidance that mandates the inclusion of overall survival (OS) data in all randomized clinical trials...
The U.S. Food and Drug Administration (FDA) has issued new draft guidance requiring that overall survival (OS) data be included in all randomized cancer drug clinical...